Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

(2010) Larry R. Smith et al.   VACCINE

Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines

(2009) Jukka Hartikka et al.   VACCINE

Vaxfectin®-adjuvanted seasonal influenza protein vaccine: Correlation of systemic and local immunological markers with formulation parameters

(2009) Mark Shlapobersky et al.   VACCINE

Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA

(2009) Adrián Vilalta et al.   VACCINE

Vaxfectin® enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses

(2009) Martha Sedegah et al.   VACCINE

TLRs and innate immunity

(2008) B. A. Beutler   BLOOD

Use of Vaxfectin Adjuvant with DNA Vaccine Encoding the Measles Virus Hemagglutinin and Fusion Proteins Protects Juvenile and Infant Rhesus Macaques against Measles Virus

(2008) C.-H. Pan et al.   Clinical and Vaccine Immunology

Plasmid DNA–Based Vaccines Protect Mice and Ferrets against Lethal Challenge with A/Vietnam/1203/04 (H5N1) Influenza Virus

(2008) Peggy A. Lalor et al.   JOURNAL OF INFECTIOUS DISEASES